Patient Guide: A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 50 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05613088
Status: ACTIVE_NOT_RECRUITING
Condition: Fallopian Tube Neoplasms, Ovarian Neoplasms
Phase: PHASE2

Where You Can Participate

This study is available at 50 locations across the country.

Top locations include:
  • • Sacramento, California
  • • San Francisco, California
  • • Whittier, California
  • • And 47 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Join Clinical Trial NCTNCT05613088

How to Join This Clinical Trial - NCTNCT05613088

Learn how to participate in this PHASE2 trial studying an investigational therapy for Fallopian Tube Neoplasms, Ovarian Neoplasms. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Fallopian Tube Neoplasms, Ovarian Neoplasms. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Fallopian Tube Neoplasms, Ovarian Neoplasms
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT05613088 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 50 locations. Find a study site near you:

Clinical Research Site

Sacramento, California 95817 - United States

Status: Contact for availability

Clinical Research Site

San Francisco, California 94109 - United States

Status: Contact for availability

Clinical Research Site

Whittier, California 90602-3171 - United States

Status: Contact for availability

Clinical Research Site

South Bend, Indiana 46601-1033 - United States

Status: Contact for availability

Clinical Research Site

Kansas City, Kansas 66160 - United States

Status: Contact for availability

Clinical Research Site

Canton, Ohio 44710-1702 - United States

Status: Contact for availability

Clinical Research Site

Columbus, Ohio 43219 - United States

Status: Contact for availability

Clinical Research Site

Nashville, Tennessee 37203-1625 - United States

Status: Contact for availability

Clinical Research Site

Salt Lake City, Utah 84124 - United States

Status: Contact for availability

Clinical Research Site

Spokane, Washington 99204 - United States

Status: Contact for availability

And 40 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Fallopian Tube Neoplasms, Ovarian Neoplasms:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships